ASP3550 Phase III Study - An Open-Label, Active-Controlled, Parallel-Arm Study, Comparing ASP3550 With Goserelin Acetate in Patients With Prostate Cancer
Phase of Trial: Phase III
Latest Information Update: 21 Sep 2016
At a glance
- Drugs Degarelix (Primary) ; Goserelin
- Indications Adenocarcinoma; Prostate cancer
- Focus Registrational; Therapeutic Use
- Sponsors Astellas Pharma
- 07 Jun 2017 Biomarkers information updated
- 07 Sep 2016 Status changed from active, no longer recruiting to completed.
- 09 Jun 2014 Trial status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.